Vivera Pharmaceuticals, Inc., EFT Global Holdings, Inc. d/b/a Sentar Pharmaceuticals, and Paul P. Edalat

SEC Charges Vivera Pharmaceuticals and Its CEO with Offering Fraud

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like
Read More

LBRY, Inc.

SEC Granted Summary Judgment Against New Hampshire Issuer of Crypto Asset Securities for Registration Violations
Read More

Mahmoud Ali Abdelkader

Litigation Release No. 25660 / March 9, 2023 Securities and Exchange Commission v. Mahmoud Ali Abdelkader, No. 3:23-cv-01032…
Read More

Ronald D. Paul

SEC Charges Former Eagle Bancorp CEO with Failing to Disclose Related Party Loans
Read More

David Stephens et al.

SEC Charges Four Defendants in Connection with Fraudulent Scheme to Sell Public Company Stock